David  Taber  to  Pharmacists
                            
                            
                                This is a "connection" page, showing publications  David  Taber  has written about  Pharmacists.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            2.761
         
        
        
     
 
    
        
        - 
            A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled Trial. Ann Pharmacother. 2022 06; 56(6):685-690.
            
            
                Score: 0.685
             
- 
            It is time for board certification in transplant pharmacotherapy. Am J Transplant. 2018 09; 18(9):2370-2371.
            
            
                Score: 0.548
             
- 
            A National Survey Assessing the Current Workforce of Transplant Pharmacists Across Accredited U.S. Solid Organ Transplant Programs. Am J Transplant. 2015 Oct; 15(10):2683-90.
            
            
                Score: 0.443
             
- 
            Significant hospitalization cost savings to the payer with a pharmacist-led mobile health intervention to improve medication safety in kidney transplant recipients. Am J Transplant. 2021 10; 21(10):3428-3435.
            
            
                Score: 0.170
             
- 
            Impact of a pharmacist-led, mHealth-based intervention on tacrolimus trough variability in kidney transplant recipients: A report from the TRANSAFE Rx randomized controlled trial. Am J Health Syst Pharm. 2021 07 09; 78(14):1287-1293.
            
            
                Score: 0.169
             
- 
            Using informatics and mobile health to improve medication safety monitoring in kidney transplant recipients. Am J Health Syst Pharm. 2019 Jul 18; 76(15):1143-1149.
            
            
                Score: 0.148
             
- 
            Development of a Predictive Model for Drug-Related Problems in Kidney Transplant Recipients. Pharmacotherapy. 2017 02; 37(2):159-169.
            
            
                Score: 0.125
             
- 
            Optimizing finite resources: Pharmacist chart reviews in an outpatient kidney transplant clinic. J Am Pharm Assoc (2003). 2015 Nov-Dec; 55(6):613-620.
            
            
                Score: 0.114
             
- 
            Improving transplant patient safety through pharmacist discharge medication reconciliation. Am J Transplant. 2013 Mar; 13(3):796-801.
            
            
                Score: 0.094
             
- 
            Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors. Am J Health Syst Pharm. 2012 Nov 15; 69(22):1993-8.
            
            
                Score: 0.093
             
- 
            Evolution of the role of the transplant pharmacist on the multidisciplinary transplant team. Am J Transplant. 2011 Aug; 11(8):1576-83.
            
            
                Score: 0.084
             
- 
            Challenges for expansion of thoracic transplant clinical pharmacy in a developing country: comparison with U.S. accredited centres and call for action. J Clin Pharm Ther. 2022 May; 47(5):588-591.
            
            
                Score: 0.043
             
- 
            Building a business plan to support a transplantation pharmacy practice model. Am J Health Syst Pharm. 2014 May 01; 71(9):751-7.
            
            
                Score: 0.026
             
- 
            Implementation of a collaborative drug therapy management service for inpatients receiving direct thrombin inhibitors. Am J Health Syst Pharm. 2009 Jul 15; 66(14):1297-303.
            
            
                Score: 0.018